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ABSTRACT 
EFFECT OF METHYLCOBALAMINE SUPPLEMENTATION ON 
HOMOCYSTEINE LEVEL CHANGES IN ISCHEMIC STROKE PATIENTS 
 
Background: Hyperhomocysteinemia (Hhcy)  is defined as a pathological 
condition in  ischemic stroke. homocysteine induces accumulation of reactive 
oxygen species (ROS) and modification of protein via homocysteinylation and 
involves functional modification of enzymes and redox balance in neuron and 
deteriorate  ischemic stroke via apoptosis mechanism. 
Method: This study was a pre-experimental study,  The subjects were patients 
(18-70 years; GCS score 456) who were admitted to the General hospital of 
Airlangga University with ischemic stroke  without dysphagia that had agreed to 
sign informed consent. Homocysteine serum level was determined by ELISA. 
Hcy level and NIHSS and measured before and after one month  after start of 
treatment. 
 
Objectives: This study aimed to analyze the effects methylcobalamin 
suplementation on Hcy level and NIHSS score in patients with ischemic stroke. 
Result: The difference in hcy serum level of the ischemic stroke patients before 
and after treatment was not significant ( 18.47±16,373 vs  16.76±15.12; P value 
0,059)so with the NIHSS score  was not significant either  (6,9±3,634 vs 6,1 ±4.7; 
P value 0,343). The correlation between difference of hcy serum level and 
decrease of NIHSS score was not significant with coefficient 0,433. 
Conclusion: Methylcobalamin supplementation has no effect on the decline in 
levels of Hcy and NIHSS value and not correlated. 
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